DelistingJun 3, 2026, 04:33 PM
Cardlytics Faces Nasdaq Delisting, Announces 1-for-10 Reverse Stock Split
AI Summary
Cardlytics, Inc. received a notice from Nasdaq regarding its common stock trading below the $1.00 minimum bid price for 30 consecutive business days, potentially leading to delisting. The company has 180 calendar days, until November 30, 2026, to regain compliance. In response, Cardlytics filed a Charter Amendment to effect a 1-for-10 reverse stock split and reduce authorized shares from 100 million to 10 million, effective June 5, 2026. Split-adjusted trading will commence on June 8, 2026, reducing outstanding shares from approximately 58.1 million to 5.8 million.
Key Highlights
- Cardlytics received Nasdaq delisting notice for bid price below $1.00.
- Company has 180 days, until November 30, 2026, to regain compliance.
- Filed Charter Amendment for 1-for-10 reverse stock split.
- Authorized shares reduced from 100,000,000 to 10,000,000.
- Reverse stock split effective 5:00 p.m. ET on June 5, 2026.
- Split-adjusted trading begins on Nasdaq Global Market on June 8, 2026.
- Outstanding shares will decrease from 58,078,634 to approximately 5,807,863.
Price Impact
More from CDLX